Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BDHK-2009 in Healthy Adult Participants
NCT07632573Phase 1Recruiting
- Sponsor
- Benethera
- Start
- May 2026
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in ulcerative colitis (UC) and Crohn's disease comparing BDHK-2009 Tablets with Placebo (2 arms). Primary endpoint: Safety and Tolerability at 4 weeks. Started May 2026; status: recruiting.
02
Drugs
BT-101
03
Conditions
ulcerative colitis (UC)Crohn's disease
Beyond the preview
Go deeper on NCT07632573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07632573.